Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Opiates, Urine Screen with Reflex to Quantitation (2005093) is recommended.
Qualitative Enzyme Immunoassay
New York DOH Approval Status
Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)
Specimens exposed to repeated freeze/thaw cycles.
Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month
Effective May 16, 2011
Cutoff concentration: 300 ng/mL
Screening results are obtained by immunoassay. Results obtained by immunoassay are not confirmed unless confirmation testing is specifically requested.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
For medical purposes only; not valid for forensic use.
This test detects morphine, hydrocodone, and similar compounds. For quantitation, see Opiates, Confirmation Only, Urine (ARUP test code 0090364).
For detection of oxycodone and/or oxymorphone, see Oxycodone/Oxymorphone Screen Only, Urine (ARUP test code 2005103). For quantitation, see Opiates, Confirmation Only, Urine (ARUP test code 0090364).
|Component Test Code*||Component Chart Name||LOINC|
|2005094||Opiates, Urn, Screen||19295-5|
- Opiates urine screen
- Urine screen for opiates